| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9490 | 
      | Human Intestinal Absorption | HIA+ | 0.9919 | 
      | Caco-2 Permeability | Caco2+ | 0.7513 | 
      | P-glycoprotein Substrate | Substrate | 0.8137 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.7791 | 
                                                     | Non-inhibitor | 0.8534 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.6647 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4936 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8217 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8575 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7024 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9189 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8878 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8643 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8427 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8899 | 
      | CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5197 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7880 | 
                                                                    | Non-inhibitor | 0.7518 | 
      | AMES Toxicity | AMES toxic | 0.9107 | 
      | Carcinogens | Non-carcinogens | 0.8649 | 
      | Fish Toxicity | High FHMT | 0.9979 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9594 | 
      | Honey Bee Toxicity | Low HBT | 0.8959 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.8000 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5950 |